| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Discovery Officer | Senior VP - Drug Discovery
1 company
Babu Yarlagadda S is a Chief Discovery Officer at BCRX. Recent filings cover 1 purchase and 4 sales. Those positions are worth an estimated $398K at current prices.
Our model assigns Babu Yarlagadda S a middling insider score of 66/100, based on 3 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +41.2%.
Babu Yarlagadda S's largest disclosed position is in BCRX as Chief Discovery Officer, worth about $398K. The recent filings there lean toward selling, a net 86,615 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2022 | BCRX Biocryst Pharmaceuticals Inc | Chief Discovery Officer | Sale+OE | 31,515 | $13.88 | $437,428.20 | -9.5% | -25.1% | -61.2% | |
| Mar 7, 2022 | BCRX Biocryst Pharmaceuticals Inc | Chief Discovery Officer | Sell | 20,000 | $17.16 | $343,200.00 | -8.0% | -40.0% | -50.2% | |
| Dec 7, 2021 | BCRX Biocryst Pharmaceuticals Inc | Chief Discovery Officer | Sale+OE | 30,100 | $12.20 | $367,220.00 | -12.3% | +42.2% | -12.2% | |
| Nov 18, 2019 | BCRX Biocryst Pharmaceuticals Inc | Senior VP - Drug Discovery | Buy | 25,000 | $1.45 | $36,250.00 | +19.1% | - | - | |
| Aug 25, 2016 | BCRX Biocryst Pharmaceuticals Inc | Senior VP - Drug Discovery | Sell | 30,000 | $4.06 | $121,800.00 | -21.2% | - | - |